We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here's Why You Should Retain ASH Stock in Your Portfolio Now
Read MoreHide Full Article
Key Takeaways
ASH is sharpening its specialty chemicals portfolio through cost cuts and operational efficiency.
Ashland generated $103 million in Q3 free cash flow and approved a new $1-billion share repurchase program.
Weak industrial demand, logistics pressures and tariffs could weigh on margins and near-term performance.
Ashland Inc. (ASH - Free Report) is focusing on cost savings, portfolio optimization and operational efficiency to strengthen margins and free cash flow while returning capital to stockholders through share repurchases. However, weak industrial demand, logistics pressures, tariff-related costs and concentration in higher-margin consumer-oriented businesses could weigh on future performance.
The company’s shares have gained 37.5% over a year against the industry’s 3.6% fall.
Image Source: Zacks Investment Research
Let’s find out why ASH stock is worth retaining at the moment.
Cost Savings and Portfolio Actions Bolster Margins for ASH
Ashland's shift to a business-unit-focused operating model supports its strategy of building a higher-margin specialty chemicals portfolio. The structure enables greater accountability, faster decision-making and stronger customer alignment. Combined with disciplined pricing, portfolio optimization and innovation, the model should support profitable growth and long-term value despite challenging demand.
Ashland's cost-reduction initiatives and portfolio-optimization actions continue to support margin resilience across its core businesses. Previously completed portfolio optimization measures are contributing to improved product mix and structural margin resilience, while ongoing restructuring and manufacturing network optimization initiatives are helping enhance operating efficiency.
Although the pace of savings has been affected by the slower productivity ramp at the Hopewell facility, management expects corrective actions to improve performance over time. The company continues to focus on higher-value, consumer-oriented specialty ingredients and innovation-driven product lines, positioning it to sustain an improved margin profile through operational discipline and a favorable business mix.
Ashland Strengthens Free Cash Flow and Shareholder Returns
Ashland is focused on increasing its free cash flow and enhancing free cash flow conversion. In the third quarter of fiscal 2026, operating activities generated $121 million in cash, while ongoing free cash flow totaled $103 million. Reaffirming its commitment to shareholder value, Ashland's board approved a new $1-billion share repurchase program, doubling its previous $500 million authorization. The company bought back about $480 million by the end of the fiscal third quarter under the new program.
Ashland Faces Concentration Risks and Tariff Headwinds
Ashland's recent earnings resilience has been driven largely by its higher-margin Life Sciences and Personal Care segments, while industrial businesses continue to face weak demand. This concentration increases the risk that weaker consumer spending, customer destocking or regulatory challenges could disproportionately affect revenue and profitability. Diversification benefits remain limited as industrial end markets recover slowly.
Ashland also faces headwinds from U.S.-China trade and tariff policies, which are raising raw material costs and pressuring margins in Life Sciences and Personal Care. The company expects tariffs on U.S. sales to China to create a roughly $70 million headwind. While pricing actions and supply-chain adjustments may help offset the impact, prolonged tariff uncertainty and higher input costs could weigh on margins and near-term financial performance.
Ashland Faces Logistics Pressure and Weak Industrial Demand
Global logistics challenges continue to pressure the specialty-chemicals sector, with higher freight costs, capacity constraints and delays raising operating expenses and weighing on margins.
Ashland also faces weak demand in its Specialty Additives business across construction, coatings and energy end markets. Despite pricing and cost-control measures, prolonged weakness could hurt volumes and earnings growth, offsetting strength in consumer-focused businesses.
The Zacks Consensus Estimate for WS’ current-year earnings stands at $3.4 per share, implying a 52.5% year-over-year increase. Its earnings beat the Zacks Consensus Estimate in two of the trailing four quarters and missed twice, with the negative average surprise being 13.8%.
The Zacks Consensus Estimate for IOSP’s fiscal current-year earnings is pegged at $5.03 per share, implying a 4.55% year-over-year decrease. Its earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, with the average surprise being 12.9%.
The Zacks Consensus Estimate for AVNT’s current-year earnings is pegged at $3.2 per share, indicating a 13.5% year-over-year increase. Its earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, with the average surprise being 3.4%.
View the Zacks #1 Rank List
Image: Bigstock
Here's Why You Should Retain ASH Stock in Your Portfolio Now
Key Takeaways
Ashland Inc. (ASH - Free Report) is focusing on cost savings, portfolio optimization and operational efficiency to strengthen margins and free cash flow while returning capital to stockholders through share repurchases. However, weak industrial demand, logistics pressures, tariff-related costs and concentration in higher-margin consumer-oriented businesses could weigh on future performance.
The company’s shares have gained 37.5% over a year against the industry’s 3.6% fall.
Image Source: Zacks Investment Research
Let’s find out why ASH stock is worth retaining at the moment.
Cost Savings and Portfolio Actions Bolster Margins for ASH
Ashland's shift to a business-unit-focused operating model supports its strategy of building a higher-margin specialty chemicals portfolio. The structure enables greater accountability, faster decision-making and stronger customer alignment. Combined with disciplined pricing, portfolio optimization and innovation, the model should support profitable growth and long-term value despite challenging demand.
Ashland's cost-reduction initiatives and portfolio-optimization actions continue to support margin resilience across its core businesses. Previously completed portfolio optimization measures are contributing to improved product mix and structural margin resilience, while ongoing restructuring and manufacturing network optimization initiatives are helping enhance operating efficiency.
Although the pace of savings has been affected by the slower productivity ramp at the Hopewell facility, management expects corrective actions to improve performance over time. The company continues to focus on higher-value, consumer-oriented specialty ingredients and innovation-driven product lines, positioning it to sustain an improved margin profile through operational discipline and a favorable business mix.
Ashland Strengthens Free Cash Flow and Shareholder Returns
Ashland is focused on increasing its free cash flow and enhancing free cash flow conversion. In the third quarter of fiscal 2026, operating activities generated $121 million in cash, while ongoing free cash flow totaled $103 million. Reaffirming its commitment to shareholder value, Ashland's board approved a new $1-billion share repurchase program, doubling its previous $500 million authorization. The company bought back about $480 million by the end of the fiscal third quarter under the new program.
Ashland Faces Concentration Risks and Tariff Headwinds
Ashland's recent earnings resilience has been driven largely by its higher-margin Life Sciences and Personal Care segments, while industrial businesses continue to face weak demand. This concentration increases the risk that weaker consumer spending, customer destocking or regulatory challenges could disproportionately affect revenue and profitability. Diversification benefits remain limited as industrial end markets recover slowly.
Ashland also faces headwinds from U.S.-China trade and tariff policies, which are raising raw material costs and pressuring margins in Life Sciences and Personal Care. The company expects tariffs on U.S. sales to China to create a roughly $70 million headwind. While pricing actions and supply-chain adjustments may help offset the impact, prolonged tariff uncertainty and higher input costs could weigh on margins and near-term financial performance.
Ashland Faces Logistics Pressure and Weak Industrial Demand
Global logistics challenges continue to pressure the specialty-chemicals sector, with higher freight costs, capacity constraints and delays raising operating expenses and weighing on margins.
Ashland also faces weak demand in its Specialty Additives business across construction, coatings and energy end markets. Despite pricing and cost-control measures, prolonged weakness could hurt volumes and earnings growth, offsetting strength in consumer-focused businesses.
Ashland Inc. Price and Consensus
Ashland Inc. price-consensus-chart | Ashland Inc. Quote
ASH’s Zacks Rank & Key Picks
ASH currently carries a Zacks Rank #3 (Hold).
Some better-ranked stocks in the Basic Materials space are Worthington Steel, Inc. (WS - Free Report) , Innospec Inc. (IOSP - Free Report) and Avient Corporation (AVNT - Free Report) . WS currently sports a Zacks Rank #1 (Strong Buy), while IOSP and AVNT carry a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for WS’ current-year earnings stands at $3.4 per share, implying a 52.5% year-over-year increase. Its earnings beat the Zacks Consensus Estimate in two of the trailing four quarters and missed twice, with the negative average surprise being 13.8%.
The Zacks Consensus Estimate for IOSP’s fiscal current-year earnings is pegged at $5.03 per share, implying a 4.55% year-over-year decrease. Its earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, with the average surprise being 12.9%.
The Zacks Consensus Estimate for AVNT’s current-year earnings is pegged at $3.2 per share, indicating a 13.5% year-over-year increase. Its earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, with the average surprise being 3.4%.